MedPath

A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation

Phase 3
Active, not recruiting
Conditions
Hepatocellular Carcinoma
Liver Cancer
Interventions
Biological: Nivolumab
Other: Placebo
Registration Number
NCT03383458
Lead Sponsor
Bristol-Myers Squibb
Brief Summary

This study will investigate if nivolumab will improve recurrence-free survival (RFS) compared to placebo in participants with HCC who have undergone complete resection or have achieved a complete response after local ablation, and who are at high risk of recurrence

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
545
Inclusion Criteria
  • Participants with a first diagnosis of HCC who have undergone a curative resection or ablation
  • Participants are eligible to enroll if they have non-viral related-HCC, or if they have HBV-HCC, or HCV-HCC
  • Child-Pugh Score 5 or 6
  • Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
Exclusion Criteria
  • Known fibrolamellar HCC, sarcomatoid HCC, or mixed cholangiocarcinoma and HCC
  • Any evidence of tumor metastasis or co-existing malignant disease
  • Participants previously receiving any prior therapy for HCC, including loco-regional therapies
  • Participants who have undergone a liver transplant or those who are in the waiting list for liver transplantation
  • Participants who have received a live/attenuated vaccine within 30 days of randomization (eg, varicella, zoster, yellow fever, rotavirus, oral polio and measles, mumps, rubella [MMR]).

Other protocol defined inclusion/exclusion criteria apply

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm ANivolumab-
Arm BPlacebo-
Primary Outcome Measures
NameTimeMethod
Recurrence-free Survival (RFS)Up to 49 months
Secondary Outcome Measures
NameTimeMethod
Time to recurrence (TTR)Up to 49 months
Overall Survival (OS)Up to 7 years

Trial Locations

Locations (175)

Local Institution - 0009

🇺🇸

Atlanta, Georgia, United States

Local Institution - 0220

🇦🇺

Herston, Queensland, Australia

Local Institution - 0272

🇺🇸

Austin, Texas, United States

Local Institution - 0153

🇬🇧

London, United Kingdom

Local Institution - 0154

🇺🇸

Seattle, Washington, United States

Local Institution - 0124

🇦🇺

Nedlands, Western Australia, Australia

Local Institution - 0242

🇷🇴

Constanta, Romania

Local Institution - 0067

🇸🇬

Singapore, Singapore

Local Institution - 0076

🇭🇰

Hong Kong, Hong Kong

Local Institution - 0254

🇦🇷

Pilar, Buenos Aires, Argentina

Local Institution - 0243

🇦🇷

Gorriti, Buenos Aires, Argentina

Local Institution - 0196

🇯🇵

Chuo-ku, Tokyo, Japan

Local Institution - 0078

🇷🇴

Bucharest, Romania

Local Institution - 0175

🇨🇳

Taoyuan, Taiwan

Local Institution - 0210

🇯🇵

Musashino-shi, Tokyo, Japan

MetroHealth Medical Center

🇺🇸

Cleveland, Ohio, United States

Local Institution - 0244

🇦🇷

Rosario, Santa FE, Argentina

Local Institution - 0248

🇨🇱

Santiago de Chile, Metropolitana, Chile

Local Institution - 0140

🇨🇳

Taichung, Taiwan

Mayo Clinic in Arizona - Phoenix

🇺🇸

Phoenix, Arizona, United States

Local Institution - 0103

🇮🇹

Padova, Italy

Arizona Oncology Associates, PC - HOPE

🇺🇸

Tucson, Arizona, United States

Local Institution - 0025

🇺🇸

Westwood, Kansas, United States

Miami VA Healthcare System

🇺🇸

Miami, Florida, United States

Local Institution - 0081

🇺🇸

Anniston, Alabama, United States

Local Institution - 0135

🇺🇸

Los Angeles, California, United States

Sylvester Comprehensive Cancer Center/ UMHC

🇺🇸

Miami, Florida, United States

Memorial Sloan Kettering Cancer Center

🇺🇸

New York, New York, United States

Local Institution - 0001

🇦🇹

Vienna, Austria

Local Institution - 0156

🇺🇸

Dallas, Texas, United States

Local Institution - 0164

🇦🇺

Adelaide, South Australia, Australia

Local Institution - 0273

🇺🇸

Tyler, Texas, United States

Local Institution - 0061

🇫🇷

Creteil Cedex, France

Local Institution - 0208

🇺🇸

New York, New York, United States

McGuire VA Medical Center

🇺🇸

Richmond, Virginia, United States

Local Institution - 0239

🇦🇺

Blacktown, New South Wales, Australia

Local Institution - 0012

🇦🇹

Graz, Austria

Local Institution - 0224

🇦🇺

Heidelberg, Victoria, Australia

Local Institution - 0068

🇧🇪

Edegem, Belgium

Local Institution - 0108

🇧🇪

Leuven, Belgium

Local Institution - 0237

🇧🇷

Cerqueira Cesar, SAO Paulo, Brazil

Local Institution - 0246

🇨🇱

Santiago, Metropolitana, Chile

Local Institution - 0052

🇫🇷

Brest, France

Local Institution - 0057

🇫🇷

Bobigny, France

Local Institution - 0019

🇩🇪

Homburg, Germany

Local Institution - 0036

🇩🇪

Magdeburg, Germany

Local Institution - 0048

🇩🇪

Mainz, Germany

Local Institution - 0222

🇫🇷

Lille, France

Local Institution - 0051

🇫🇷

Lyon Cedex 04, France

Local Institution - 0043

🇫🇷

Montpellier Cedex, France

Local Institution - 0096

🇩🇪

Muenchen, Germany

Local Institution - 0050

🇩🇪

Koln, Germany

Local Institution - 0098

🇫🇷

Reims, France

Local Institution - 0093

🇩🇪

Frankfurt am Main, Germany

Local Institution - 0040

🇩🇪

Hannover, Germany

Local Institution - 0037

🇫🇷

Nice, France

Local Institution - 0008

🇩🇪

Tuebingen, Germany

Local Institution - 0070

🇷🇴

Timisoara, Romania

Local Institution - 0069

🇪🇸

Barcelona, Spain

Local Institution - 0016

🇪🇸

Córdoba, Spain

Local Institution - 0183

🇯🇵

Kashiwa-shi, Chiba, Japan

Local Institution - 0189

🇰🇷

Seoul, Korea, Republic of

Local Institution - 0186

🇯🇵

Shinjuku-ku, Tokyo, Japan

Local Institution - 0109

🇪🇸

Madrid, Spain

Fondazione Policlinico Gemelli - Universita Cattolica del Sacro Cuore

🇮🇹

Rome, Italy

Local Institution - 0200

🇯🇵

Sapporo-shi, Hokkaido, Japan

Local Institution - 0177

🇰🇷

Daegu, Korea, Republic of

Local Institution - 0201

🇯🇵

Kurume-shi, Fukuoka, Japan

Local Institution - 0128

🇰🇷

Seoul, Korea, Republic of

Local Institution - 0215

🇯🇵

Bunkyo-ku, Tokyo, Japan

Local Institution - 0191

🇰🇷

Suwon-si, Gyeonggi-do, Korea, Republic of

Local Institution - 0127

🇰🇷

Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of

Local Institution - 0185

🇯🇵

Tokushima-shi, Tokushima, Japan

Local Institution - 0188

🇰🇷

Gyeongsangnam-do, Korea, Republic of

Local Institution - 0231

🇵🇷

San Juan, Puerto Rico

Local Institution - 0264

🇲🇽

Monterrey, Nuevo Leon, Mexico

Local Institution - 0121

🇲🇽

Monterrey, Nuevo León, Mexico

Local Institution - 0260

🇳🇱

Utrecht, Netherlands

Local Institution - 0226

🇲🇽

San Luis Potosi, Mexico

Local Institution - 0240

🇳🇿

Auckland, New Zealand

Local Institution - 0148

🇲🇽

Cuauhtemoc, Durango, Mexico

Local Institution - 0263

🇳🇱

Maastricht, Netherlands

Local Institution - 0042

🇸🇬

Singapore, Singapore

Local Institution - 0031

🇪🇸

Barcelona, Spain

Local Institution - 0176

🇨🇳

Yunlin, Taiwan

Local Institution - 0100

🇪🇸

Pamplona, Spain

Local Institution - 0028

🇪🇸

Sevilla, Spain

Local Institution - 0102

🇮🇹

Bologna, Italy

Local Institution - 0091

🇮🇹

Milano, Italy

Local Institution - 0134

🇮🇹

Monserrato, Italy

Local Institution - 0119

🇮🇹

Napoli, Italy

Local Institution - 0077

🇮🇹

Firenze, Italy

Local Institution - 0104

🇮🇹

Meldola, Italy

Azienda Ospedaliera Specialistica dei Colli Monaldi-Cotugno-CTO

🇮🇹

Napoli, Italy

Local Institution - 0023

🇧🇷

Sao Paulo, Brazil

Local Institution - 0184

🇯🇵

Sapporo-shi, Hokkaido, Japan

Local Institution - 0216

🇯🇵

Nishinomiya-shi, Hyogo, Japan

Local Institution - 0202

🇯🇵

Kumamoto-shi, Kumamoto, Japan

Local Institution - 0257

🇯🇵

Morioka-shi, Iwate, Japan

Local Institution - 0179

🇯🇵

Hiroshima, Japan

Local Institution - 0197

🇯🇵

Kanagawa, Japan

CHU Estaing

🇫🇷

Clermont Ferrand, France

Local Institution - 0212

🇫🇷

Rennes Cedex 9, France

Local Institution - 0044

🇫🇷

Saint-Priest-en-Jarez, France

Local Institution - 0011

🇫🇷

Vandoeuvre Les Nancy Cedex, France

Universitatsmedizin Mannheim

🇩🇪

Mannheim, Germany

Local Institution - 0097

🇪🇸

Zaragoza, Spain

Local Institution - 0166

🇦🇺

Camperdown, New South Wales, Australia

Local Institution - 0219

🇺🇸

White Plains, New York, United States

Local Institution - 0141

🇦🇺

Concord, New South Wales, Australia

Local Institution - 0275

🇧🇷

Barretos, Sao Paulo, Brazil

Local Institution - 0054

🇫🇷

Villejuif, France

Local Institution - 0088

🇺🇸

Palo Alto, California, United States

Local Institution - 0085

🇺🇸

San Francisco, California, United States

Local Institution - 0075

🇺🇸

New York, New York, United States

Local Institution - 0209

🇺🇸

Saint Louis, Missouri, United States

Minnesota Oncology Hematology, P.A.

🇺🇸

Minneapolis, Minnesota, United States

Local Institution - 0206

🇺🇸

Portland, Oregon, United States

Texas Oncology Sammons Cancer Center

🇺🇸

Dallas, Texas, United States

Local Institution - 0235

🇺🇸

Aurora, Colorado, United States

Local Institution - 0163

🇺🇸

Tampa, Florida, United States

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

Local Institution - 0033

🇧🇪

Brussels, Belgium

Local Institution - 0003

🇦🇹

Wien, Austria

Local Institution - 0071

🇧🇪

Gent, Belgium

Local Institution

🇷🇺

Leningrad Region, Russian Federation

Local Institution - 0090

🇧🇷

Belo Horizonte, Minas Gerais, Brazil

Local Institution - 0236

🇧🇷

Sao Paulo, Brazil

Local Institution - 0116

🇨🇦

Edmonton, Canada

Local Institution - 0245

🇨🇱

Santiago, Región Metropolitana De Santiago, Chile

Local Institution - 0247

🇨🇱

Vina del Mar, Valparaiso, Chile

Local Institution - 0256

🇨🇴

Bogota, Colombia

Local Institution - 0046

🇫🇷

Clichy, France

Local Institution - 0232

🇷🇴

Cluj-Napoca, Romania

Local Institution - 0013

🇫🇷

Grenoble Cedex 09, France

Local Institution - 0074

🇷🇴

Craiova, Romania

Local Institution - 0020

🇩🇪

Bonn, Germany

Local Institution - 0026

🇩🇪

Essen, Germany

Local Institution - 0024

🇩🇪

Aachen, Germany

Local Institution - 0258

🇩🇪

Berlin, Germany

Local Institution - 0136

🇮🇹

Messina, ME, Italy

Local Institution - 0187

🇯🇵

Chiba-shi, Chiba, Japan

Local Institution - 0180

🇯🇵

Kanazawa-shi, Ishikawa, Japan

Local Institution - 0203

🇯🇵

Osaka-shi, Osaka, Japan

Local Institution - 0198

🇯🇵

Osaka-shi, Osaka, Japan

Local Institution - 0214

🇯🇵

Suita-shi, Osaka, Japan

Local Institution - 0182

🇯🇵

Mitaka-shi, Tokyo, Japan

Local Institution - 0190

🇰🇷

Goyang-si, Korea, Republic of

Local Institution - 0178

🇰🇷

Jeollanam-do, Korea, Republic of

Local Institution - 0129

🇨🇳

Taipei, Taiwan

Local Institution - 0169

🇰🇷

Seongnam-si, Korea, Republic of

Local Institution - 0168

🇰🇷

Seoul, Korea, Republic of

Local Institution - 0167

🇰🇷

Seoul, Korea, Republic of

Local Institution - 0195

🇰🇷

Seoul, Korea, Republic of

Local Institution - 0032

🇷🇺

St. Petersburg, Sankt-Peterburg, Russian Federation

Arkhangelsk Clinical Oncological Dispensary

🇷🇺

Arkhangelsk, Russian Federation

Local Institution - 0230

🇷🇺

Moscow, Russian Federation

Local Institution - 0039

🇸🇬

Singapore, Singapore

Local Institution - 0072

🇪🇸

Donostia-San Sebastian, Spain

Local Institution - 0199

🇪🇸

Madrid, Spain

Local Institution - 0010

🇪🇸

Sabadell (Barcelona), Spain

Local Institution - 0131

🇨🇳

Tainan, TNN, Taiwan

Local Institution - 0082

🇪🇸

Valencia, Spain

Local Institution - 0204

🇨🇳

Kaohsiung, Taiwan

Local Institution - 0130

🇨🇳

Taichung, Taiwan

Local Institution - 0174

🇨🇳

Tainan, Taiwan

Local Institution - 0207

🇨🇳

Taipei, Taiwan

Local Institution - 0173

🇨🇳

Taipei, Taiwan

Local Institution - 0111

🇬🇧

London, United Kingdom

Local Institution - 0114

🇬🇧

Manchester, United Kingdom

Local Institution - 0092

🇬🇧

London, United Kingdom

Local Institution - 0142

🇬🇧

Wirral, United Kingdom

Local Institution - 0064

🇧🇪

Bruxelles, Belgium

Local Institution - 0086

🇺🇸

New Orleans, Louisiana, United States

Local Institution - 0120

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath